Taiwan FDA registration 592ff47c79ddd5ae889da382c09da778
"Demanson" Lipolylase Flax Reagent Set (Unsterilized)
TW: "德曼遜" 脂解酶弗列克斯試劑組 (未滅菌)
Taiwan·Risk Class 1·SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered Nov 10, 2022 – Nov 10, 2027ActiveRegistration details
- Analysis ID
- 592ff47c79ddd5ae889da382c09da778
- Customs Code
- DHA09402294909
Company information
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS INC.
- Manufacturer Country
- United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
Product details
- Intended Use
- Limited to the classification and grading management of medical equipment "Lipolytic enzyme test system (A.1465)" the first level identification range.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1465 Lipolytic enzyme testing system
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- Nov 10, 2022
- Expiry Date
- Nov 10, 2027
About this record
Access comprehensive regulatory information for "Demanson" Lipolylase Flax Reagent Set (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 592ff47c79ddd5ae889da382c09da778 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices